Literature DB >> 18445995

Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population.

Kimie Sai1, Yoshiro Saito, Masaya Itoda, Hiromi Fukushima-Uesaka, Tomoko Nishimaki-Mogami, Shogo Ozawa, Keiko Maekawa, Kouichi Kurose, Nahoko Kaniwa, Manabu Kawamoto, Naoyuki Kamatani, Kuniaki Shirao, Tetsuya Hamaguchi, Noboru Yamamoto, Hideo Kunitoh, Yuichiro Ohe, Yasuhide Yamada, Tomohide Tamura, Teruhiko Yoshida, Hironobu Minami, Yasuhiro Matsumura, Atsushi Ohtsu, Nagahiro Saijo, Jun-ichi Sawada.   

Abstract

The multidrug resistance-associated protein 2 (MRP2) encoded by the ABCC2 gene is expressed in the liver, intestine and kidneys and preferentially exports organic anions or conjugates with glucuronide or glutathione. In this study, all 32 exons and the 5'-flanking region of ABCC2 in 236 Japanese were resequenced, and 61 genetic variations including 5 novel nonsynonymous ones were detected. A total of 64 haplotypes were determined/inferred and classified into five *1 haplotype groups (*1A, *1B, *1C, *1G, and *1H) without nonsynonymous substitutions and *2 to *9 groups with nonsynonymous variations. Frequencies of the major 4 haplotype groups *1A (-1774delG), *1B (no common SNP), *1C (-24C>T and 3972C>T), and *2 [1249G>A (Val417Ile)] were 0.331, 0.292, 0.172, and 0.093, respectively. This study revealed that haplotype *1A, which has lowered activity, is quite common in Japanese, and that the frequency of *1C, another functional haplotype, was comparable to frequencies in Asians and Caucasians. In contrast, the haplotypes harboring 3972C>T but not -24C>T (*1G group), which are reportedly common in Caucasians, were minor in Japanese. Moreover, the allele 1446C>T (Thr482Thr), which has increased activity, was not detected in our Japanese population. These findings imply possible differences in MRP2-mediated drug responses between Asians and Caucasians.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445995     DOI: 10.2133/dmpk.23.139

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  8 in total

1.  Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers.

Authors:  Dong Guo; Liang-Fang Pang; Yang Han; Hong Yang; Guo Wang; Zhi-Rong Tan; Wei Zhang; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2012-10-10       Impact factor: 2.953

2.  No correlation between MTHFR c.677 C > T, MTHFR c.1298 A > C, and ABCB1 c.3435 C > T polymorphisms and methotrexate therapeutic outcome of rheumatoid arthritis in West Algerian population.

Authors:  Wefa Boughrara; Ahmed Benzaoui; Meriem Aberkane; Fatima Zohra Moghtit; Samia Dorgham; Aicha Sarah Lardjam-Hetraf; Hadjer Ouhaibi-Djellouli; Elisabeth Petit Teixeira; Abdallah Boudjema
Journal:  Inflamm Res       Date:  2017-03-15       Impact factor: 4.575

Review 3.  Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.

Authors:  Deirdre P Cronin-Fenton; Per Damkier; Timothy L Lash
Journal:  Future Oncol       Date:  2014-01       Impact factor: 3.404

4.  MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer.

Authors:  Ning Sun; Xinchen Sun; Baoan Chen; Hongyan Cheng; Jifeng Feng; Lu Cheng; Zuhong Lu
Journal:  Cancer Chemother Pharmacol       Date:  2009-07-01       Impact factor: 3.333

Review 5.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

Review 6.  The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review.

Authors:  Wefa Boughrara; Amina Chentouf
Journal:  Acta Neurol Belg       Date:  2022-03-24       Impact factor: 2.471

7.  Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.

Authors:  Eugenia Ulzurrun; Camilla Stephens; Francisco Ruiz-Cabello; Mercedes Robles-Diaz; Pablo Saenz-López; Hacibe Hallal; German Soriano; Eva Roman; M Carmen Fernandez; M Isabel Lucena; Raúl J Andrade
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

8.  Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma.

Authors:  Katja Goricar; Viljem Kovac; Vita Dolzan
Journal:  Radiol Oncol       Date:  2014-04-25       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.